Vimarsana
Biggest News Aggregation in the World

Il 36 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Il 36. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Il 36 Today - Breaking & Trending Today

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares - Vimarsana News

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares

Dermatologists Drs Tina Bhutani and Scott Boswell discuss use of spesolimab to treat generalized pustular psoriasis (GPP) flares.

Use of Biologics in Rare Dermatologic Disorders - Vimarsana News

Use of Biologics in Rare Dermatologic Disorders

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares - Vimarsana News

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

EFFISAYIL™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in adolescents and adults with generalized pustular psoriasis (GPP) up to 48 weeks.1,2